ALDA Buyers and Pharmaceuticals Medication Mart sign distribution contract ALDA Pharmaceuticals Corp. Dr. Terrance Owen, President & CEO, says: ‘This agreement provides ALDA with widespread nationwide distribution of our products to consumers for the very first time.’.John Holaday, Managing CEO and Director, QRxPharma: After analysis of several other licensing proposals, it was very clear Actavis was the strategic choice for the Company. Their knowledge in the making, distribution, marketing and product sales of both patented and generic opioid products enabled a partnership framework with QRxPharma which will accelerate revenues and maximise shareholder value. The workout of the choice for MoxDuo CR by Actavis is contingent upon the achievement of certain sales milestones for MoxDuo IR. The choice for MoxDuo IV shall lapse on a day certain if not exercised by Actavis.
AIDS, tuberculosis, bird and malaria flu pass on unchecked in Burma Government guidelines in Burma that restrict open public health and humanitarian help have created an environment where Helps, drug-resistant tuberculosis, malaria and bird flu are spreading unchecked, according to a report by researchers at the Johns Hopkins Bloomberg College of Public Health.